Sarah Urbani-Garrido
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inhibition of host NOX1 blocks tumor growth and enhances checkpoint inhibitor-based immunotherapy.
Journal: Life science alliance
Published: December 06, 2018
Junctional adhesion molecule C (JAM-C) dimerization aids cancer cell migration and metastasis.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: September 02, 2017
Inhibitory role of oxytocin on TNFα expression assessed in vitro and in vivo.
Journal: Diabetes & metabolism
Published: July 25, 2017
Noxs on tumour's door: oxidative stress drives tumour vascularization.
Journal: Acta physiologica (Oxford, England)
Published: January 28, 2016
Proteomic peptide phage display uncovers novel interactions of the PDZ1-2 supramodule of syntenin.
Journal: FEBS letters
Published: October 23, 2015
ROS and NADPH oxidase: key regulators of tumor vascularisation
Journal: Medecine sciences : M/S
Published: May 08, 2014
Tight junction dynamics: the role of junctional adhesion molecules (JAMs).
Journal: Cell and tissue research
Published: November 27, 2013
Immunological aspects of atherosclerosis.
Journal: Seminars in immunopathology
Published: May 29, 2013
Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage.
Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage.
Journal: Molecular cancer therapeutics
Published: September 25, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026